Published • loading... • Updated
Eledon Teams Up With Natera on Phase 3 Study - Orange County Business Journal
Summary by ocbj.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Eledon Teams Up With Natera on Phase 3 Study - Orange County Business Journal
Irvine-based biotech company Eledon Pharmaceuticals Inc. today announced a partnership with Natera to use Natera’s Prospera kidney transplant assessment test in Eledon’s upcoming Phase 3 clinical trial. The trial will evaluate Eledon’s tegoprubart, an investigational therapy to prevent organ rejection in kidney transplantation. The Prospera test can detect early signs of transplant rejection, helping doctors decide whether further testing, inclu…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
